Article
BRAF Heterogeneity in Melanoma.
Current treatment options in oncology - 8 Feb 2021
Ito Takamichi, Tanaka Yuka, Murata Maho, Kaku-Ito Yumiko, Furue Kazuhisa, Furue Masutaka
Abstract excerpt
OPINION STATEMENT: In the era of molecular targeted therapy, the accurate detection of BRAF mutation in melanoma has become increasingly important. With the advances of molecular analyses and immunohistochemistry, the presence of BRAF mutational heterogeneity in melanoma has been widely recognized. Although most patients with melanoma have a homogeneous BRAF mutation status because the BRAF mutation occurs at an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
